Mrs. Dianne M. Crea-powers, MSCCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6917 W Bergen Rd, Bergen, NY 14416 Phone: 585-494-2220 |
News Archive
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
According to the Federation of Small Businesses, there are 5.5 small businesses across the UK and the awards they organize help to promote and recognize innovation, enterprise and accomplishment in 12 areas across the UK. Bedfont is proud to have been shortlisted in 3 categories for the South East: Business Exporter of the Year, Family Business of the Year and Employer of the Year.
The week of Christmas left no one turned away from the Emergency Department at United Hospital Center in Clarksburg, West Virginia. For the first time in years, a zero LWOT (Left Without Treatment) metric appeared on the hospital dashboard.
Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior Vice President and Chief Medical Officer, and Chris Rusconi, Ph.D., Senior Vice President and Chief Scientific Officer, presented a poster about REG3 at the AHA Scientific Sessions meeting.
Women fighting breast cancer after a lumpectomy have a new weapon in the battle, now available at Jupiter Medical Center's Foshay Cancer Center. Today, the hospital began treating patients with the Multi-Lumen MammoSite(R) device, just approved in September by the FDA.
› Verified 3 days ago